RecruitingPhase 2NCT07189234

Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health

TIMET 2.0 - Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health


Sponsor

University of California, San Diego

Enrollment

140 participants

Start Date

Oct 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In a randomized controlled trial, the investigators intend to measure the health impact of time restricted eating (TRE) in patients with metabolic syndrome (with elevated blood pressure and at least 2 of the following: increased waist circumference, abnormal cholesterol levels, elevated triglycerides, and elevated fasting glucose levels), who habitually eat more than 12 hours every day. Patients will be randomly assigned to a control group (standard of care) or intervention group (TRE).


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria11

  • Age: 18-75 years
  • HbA1c: 5.7% to 7.0%
  • Metabolic syndrome (must meet 3 criteria):
  • Elevated systolic blood pressure ≥ 130 mm Hg or diastolic blood pressure ≥ 85 mm Hg OR an antihypertensive therapy)
  • Elevated waist circumference:
  • \- In Asians: ≥ 90 cm in men, ≥80 cm in women In all other races: ≥ 102 cm in men, ≥ 88 cm in women
  • Fasting plasma triglycerides ≥ 150 mg/dL, or on drug treatment for elevated triglycerides d) Reduced High-density lipoprotein (HDL)- cholesterol < 40 mg/dL in males or < 50 mg//dL in females, or drug treatment for reduced HDL-cholesterol e) Fasting glucose ≥ 100 mg/dL
  • Own a smartphone (Apple iOS or Android OS)
  • Baseline eating period ≥12 hour/day
  • Patients on a stable dose of cardiovascular medications (HMG CoA reductase inhibitors \[statins\]), other lipid-modifying drugs (including over-the-counter drugs such as red yeast rice and fish oil), or anti-hypertensive drugs) for at least 1 month are allowed.
  • Patients on GLP-1 R agonists, SGLT2 inhibitors, or Metformin must be on stable doses for at least 3 months.

Exclusion Criteria20

  • Use of sulfonylurea or insulin.
  • HbA1C > 7.0%
  • Pregnant or breastfeeding. Anyone of reproductive age will receive pregnancy test prior to DXA scan.
  • Caregiver for a dependent requiring frequent nocturnal care / sleep interruptions.
  • Shift workers with variable (e.g. nocturnal) hours.
  • Frequent travel to different time zones during the study period.
  • Active tobacco use or illicit drug use or history of treatment for alcohol abuse.
  • History of major adverse cardiovascular event within the past year (acute coronary syndrome, percutaneous coronary intervention, coronary artery bypass graft surgery, hospitalization for congestive heart failure, stroke/transient ischemic attack).
  • History of surgical intervention for weight management within the past 2 years, or longer if deemed unsafe following review by medical investigators
  • History of thyroid disease requiring dose titration of thyroid replacement medication(s) within the past 3 months (i.e. hypothyroidism on a stable dose of thyroid replacement therapy is not an exclusion).
  • History of adrenal disease.
  • History of malignancy undergoing active treatment, except non-melanoma skin cancer.
  • Known history of type 1 diabetes.
  • History of an eating disorder.
  • History of cirrhosis.
  • History of stage 4 or 5 chronic kidney disease or requiring dialysis.
  • Currently enrolled in a weight-loss or weight-management program.
  • On a special or prescribed diet for other reasons (e.g. Celiac disease).
  • Uncontrolled psychiatric disorder (including history of hospitalization for psychiatric illness).
  • Inability or unwillingness to utilize the mCC app throughout study duration.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTime-restricted eating (TRE) + Standard of Care

Participants in this arm will adhere to a daily, consistent 10-hour eating window for the course of the study as well as receive nutritional counseling from the study dietician.

BEHAVIORALStandard of Care

Participants in this arm will receive nutritional counseling from the study dietician, but will not be required to adopt the 10-hour eating window.


Locations(1)

Altman Clinical and Translational Research Institute

La Jolla, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07189234


Related Trials